Differential Susceptibility of NSCLC and GBM Cancer Cells to Ascorbate
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
O2- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate
Cancer Cell 2017 Apr 10;31(4)487-500.e8, JD Schoenfeld, ZA Sibenaller, KA Mapuskar, BA Wagner, KL Cramer-Morales, M Furqan, S Sandhu, TL Carlisle, MC Smith, T Abu Hejleh, DJ Berg, J Zhang, J Keech, KR Parekh, S Bhatia, V Monga, KL Bodeker, L Ahmann, S Vollstedt, H Brown, EP Shanahan Kauffman, ME Schall, RJ Hohl, GH Clamon, JD Greenlee, MA Howard, MK Shultz, BJ Smith, DP Riley, FE Domann, JJ Cullen, GR Buettner, JM Buatti, DR Spitz, BG AllenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.